Steroid-refractory acute graft versus host disease
Clinical trials for Steroid-refractory acute graft versus host disease explained in plain language.
Never miss a new study
Get alerted when new Steroid-refractory acute graft versus host disease trials appear
Sign up with your email to follow new studies for Steroid-refractory acute graft versus host disease, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cord blood cells join forces with drug to fight transplant complication
Disease control Recruiting nowThis early study tests whether adding special cells from donated umbilical cord blood (called mesenchymal stromal cells) to the drug ruxolitinib can help control severe graft-versus-host disease (GVHD) that hasn't improved with steroids. GVHD is a serious complication where donor…
Matched conditions: STEROID-REFRACTORY ACUTE GRAFT VERSUS HOST DISEASE
Early phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Ancient herb takes on transplant complication: Withaferin-A tested for Steroid-Resistant GVHD
Disease control Recruiting nowThis phase 2 trial tests whether a standardized extract from the ashwagandha plant, called Withaferin-A, can help people who develop graft-versus-host disease after a stem cell transplant and whose condition does not improve with steroids. The study enrolls 34 patients aged 12 an…
Matched conditions: STEROID-REFRACTORY ACUTE GRAFT VERSUS HOST DISEASE
Phase 2 • Sponsor: Tata Memorial Centre • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Ancient heat therapy tested for Life-Threatening transplant complication
Disease control Recruiting nowThis study tests whether moxibustion, a traditional Chinese medicine technique that involves burning dried mugwort near the skin, can help people with a severe complication of stem cell transplants called graft-versus-host disease (GVHD) that does not respond to steroids. The tri…
Matched conditions: STEROID-REFRACTORY ACUTE GRAFT VERSUS HOST DISEASE
Phase 2 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC